• Presented at International Society for Pharmacoeconomics and Outcomes Research  (ISPOR) (2021)

  • Collaborator: Roche Diabetes Care

  • Authors: Cerletti P, Van Haelst P, Gyldmark M, Varriale P, Wilczynski O

Although the field of Digital Health Solutions (DHS) for improving outcomes in diabetes has evolved rapidly over the last 20 years, there are still significant challenges in generating relevant evidence and demonstrating the value such solutions bring to patients and the overall health-care value chain.

Objective:  This research was conducted to review guidelines from national health authorities regarding patient outcomes to consider in the evaluation of DHS and to determine if existing Patient-Reported Outcome Measures (PROMs) are adequate tools for assessing the value of DHS.